Infinity Pharmaceuticals, Inc.
(NASDAQ : INFI)

( )
INFI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.95%408.840.0%$5581.83m
BNTXBioNTech SE -7.91%307.090.0%$959.22m
NVAXNovavax, Inc. -6.90%231.0479.4%$918.58m
SNSSSunesis Pharmaceuticals, Inc. -3.24%8.370.7%$585.09m
AMGNAmgen, Inc. -0.23%213.111.4%$539.22m
GILDGilead Sciences, Inc. -1.10%70.411.0%$450.06m
REGNRegeneron Pharmaceuticals, Inc. -3.10%619.072.7%$422.20m
ILMNIllumina, Inc. -1.67%425.583.5%$353.17m
BIIBBiogen, Inc. -1.75%286.621.7%$310.33m
VRTXVertex Pharmaceuticals, Inc. -0.11%183.411.9%$248.50m
ISEEIVERIC bio, Inc. 6.90%17.500.0%$218.29m
LIFEaTyr Pharma, Inc. -3.42%9.902.1%$159.03m
BGNEBeiGene Ltd. -0.62%377.181.3%$147.82m
TECHBio-Techne Corp. -5.09%511.454.5%$138.52m
KDMNKadmon Holdings, Inc. 0.11%8.840.8%$135.49m

Company Profile

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.